Dicot Pharma AB · LSX:A2PQTV

Dicot Pharma AB financial statements

Dicot Pharma AB's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in SEK

Income statement

LineFY2025FY2024FY2023FY2022FY2021
Revenue00000
Selling, general and administrative23.9M
Operating income-82.6M-59.3M-45.0M-31.8M-27.3M
Depreciation and amortization06.00K8.00K7.55K7.55K
EBITDA-82.6M-59.3M-45.0M-31.8M-27.2M
Interest expense6.00K10.0K66.0K33.1K3.87K
Income before tax-80.2M-57.7M-44.2M-31.8M-27.2M
Net income-80.2M-57.7M-44.2M-31.8M-27.2M
Earnings per share, basic-0.04-0.03-0.04-0.10-0.13

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021
Cash and equivalents69.2M113.4M47.3M9.38M30.3M
Receivables8.30M4.80M
Inventory8.00M5.38M3.40M1.49M0
Current assets85.5M123.6M53.5M12.4M31.7M
Total assets85.5M123.6M53.6M12.4M31.8M
Accounts payable6.12M6.84M4.54M3.42M2.58M
Current liabilities12.1M12.0M9.16M7.01M3.42M
Total liabilities12.1M12.0M9.16M7.01M3.42M
Shareholders' equity73.4M111.7M44.4M5.36M28.4M
Shares outstanding2.26B2.00B1.25B315.9M211.2M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021
Cash from operations-85.9M-58.9M-45.2M-29.7M-25.9M
Capital spending00000
Free cash flow-85.9M-58.9M-45.2M-29.7M-25.9M
Change in cash-44.2M66.1M38.0M-21.0M10.0M